Get started
Author

Carlo Putzu

Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab
2018 · Carlo Putzu, Diego Luigi Cortinovis, et al. · Cancer Immunology Immunotherapy · 76
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial
2019 · Francesco Perrone, Michelino De Laurentiis, et al. · European Journal of Cancer · 71
Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate
2007 · H. Joensuu, F. De Braud, et al. · Annals of Oncology · 64
PDF
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
2016 · Grazia Palomba, Valentina Doneddu, et al. · Journal of Translational Medicine · 63
PDF
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study
2019 · M.E. Cazzaniga, G. Pinotti, et al. · The Breast · 56
Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations
2018 · Antonio Passaro, Arsela Prelaj, et al. · Clinical Lung Cancer · 54
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer
2016 · E. Vrdoljak, N. Marschner, et al. · Annals of Oncology · 46
PDF
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)
2006 · P. Comella, G. Filippelli, et al. · Annals of Oncology · 46
PDF
Duration of Immunotherapy in Non-Small Cell Lung Cancer Survivors: A Lifelong Commitment?
2023 · Carlo Putzu, Stefania Canova, et al. · Cancers · 42
PDF
Oligometastatic Non–Small Cell Lung Cancer: A Multidisciplinary Approach in the Positron Emission Tomographic Scan Era
2006 · Tommaso M. De Pas, Filippo de Braud, et al. · The Annals of Thoracic Surgery · 28
MTHFR, XRCC1 and OGG1 genetic polymorphisms in breast cancer: a case-control study in a population from North Sardinia
2020 · Matteo Floris, Daria Sanna, et al. · BMC Cancer · 25
PDF
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
2021 · M. E. Cazzaniga, I. Vallini, et al. · Breast Cancer Research and Treatment · 17
Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group
2009 · Pasquale Comella, Vito Lorusso, et al. · Cancer Chemotherapy and Pharmacology · 16
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study
2022 · Panagiotis Paliogiannis, Maria Colombino, et al. · BMC Pulmonary Medicine · 15
PDF
ecancermedicalscience
2016 · Daniela Lepanto, Fausto Maffini, et al. · ecancermedicalscience · 14
PDF
Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms in TP53, MDM2 and ATM genes in Sardinian women
2022 · Matteo Floris, Giovanna Pira, et al. · Oncology Letters · 13
PDF
The HOBOE-2 multicenter randomized phase III trial in premenopausal patients with hormone-receptor positive early breast cancer comparing triptorelin plus either tamoxifen or letrozole or letrozole + zoledronic acid
2018 · F. Perrone, M. De Laurentiis, et al. · Annals of Oncology · 11
KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research
2025 · Maria Colombino, Grazia Palomba, et al. · Critical Reviews in Oncology/Hematology · 10
Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy
2024 · Carlo Putzu, Riccardo Serra, et al. · Current Oncology · 10
PDF
Gemcitabine combined with either pemetrexed or paclitaxel in the treatment of advanced non-small cell lung cancer
2009 · Pasquale Comella, Vincenzo E. Chiuri, et al. · Lung Cancer · 10
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients
2025 · A. Gravina, P. Gargiulo, et al. · ESMO Open · 9
PDF
Bronchial mucoepidermoid carcinoma
2017 · Alessandro G. Fois, Gabriella Diana, et al. · International Journal of Surgery Case Reports · 9
PDF
Deciduoid mesothelioma of the thorax: A comprehensive review of the scientific literature
2016 · Panagiotis Paliogiannis, Carlo Putzu, et al. · The Clinical Respiratory Journal · 8
PDF
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients
2023 · B. Trevisan, F. F. Pepe, et al. · Scientific Reports · 5
PDF
Intra-patient alternated dose escalation of paclitaxel and gemcitabine versus paclitaxel followed by fixed dose rate infusion of gemcitabine in fit elderly non-small cell lung cancer patients
2007 · Pasquale Comella, Carlo Putzu, et al. · Lung Cancer · 5
Works count: 50
Citation count: 770
H-index: 15
I10-index: 21
Year
Topic
Type